It has been clearly shown that elevated blood leptin levels are associated with the incidence of ACS and predict the short-term occurrence of congestive heart failure (CHF) or cardiac death in patients with CAD independent of obesity status and traditional cardiovascular risk factors13,14. This evidence concerns the gene LEP and congestive heart failure.